Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-44.77	68.36	123.77
Graham Fair Price	40.89	7.65	5.43
PEG	-64.15	-0.48	1.33
Price/Book	-18.83	1.45	1.79
Price/Cash Flow	76.78	-24.21	-104.28
Prices/Earnings	-57.88	22.03	52.29
Price/Sales	-13.77	6.58	7.63
Price/FCF	76.78	-24.21	-104.28
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	8.41	0.15	0.13
Operating Margin	84.61	0.08	0.04
ROA	84.38	0.01	< 0.005
ROE	< 0.005	0.02	92.71
ROIC	< 0.005	0.01	36.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	1.20	0.05	2423.38
Dividends QOQ	0.24	-0.08	-65.12
EBIT QOQ	-0.60	0.77	28.66
EPS QOQ	0.39	-0.46	17.48
FCF QOQ	0.74	-2.55	247.23
Revenue QOQ	-0.16	-0.04	73.68
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	61.73	66.07	7.03
Days Sales Outstanding (DSO)	222.24	227.00	2.14
Inventory Turnover	1.46	1.36	-6.57
Debt/Capitalization	0.16	0.29	81.97
Quick Ratio	2.29	2.08	-9.25
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	12.37	12.55	1.49
Cash	4.65	5.58	19.91
Capex	-0.04	-0.24	-575.95
Free Cash Flow	-0.21	-0.75	-254.77
Revenue	2.90	2.77	-4.46
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.67	2.43	-8.68
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-13.78	-1.08	92.15
Naive Interpretation	Member

06 - Financial Health · Bad

Rating